ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #6,718Hybrid

Annals of Pharmacotherapy

Abbreviation (ISO):ANN. PHARMACOTHER
•
Identifier (ISSN):1060-0280(Print)/1542-6270(Online)
•
Publisher:SAGE Publications Inc.
Clarivate IF (2026)
2.5↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Annals of Pharmacotherapy

WoS Q3
12452.7720182.4420192.4120203.1520213.4620222.920232.320242.320252.52026
Annual Impact Factor Metric
Current (2026):2.5
Scopus SJR & RankScopus Q2
0.815
#6,718

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
129

129 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
179articles/year
5.83% Gold OA•60.99% Original Research

Aims & Scope

Annals of Pharmacotherapy (AOP) is a peer-reviewed journal that advances pharmacotherapy throughout the world by publishing high-quality research and review articles to achieve the most desired health outcomes.The articles provide cutting-edge information about the most efficient, safe and cost-effective pharmacotherapy for the treatment and prevention of various illnesses. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 14 days

Topics Covered (Recognized by AI)
Medicine99.9%Biology79.9%Internal medicine71.3%Chemistry45.9%Psychology45%Pharmacology44.8%Psychiatry41.4%Pathology39.2%Biochemistry38.8%Surgery38.3%Genetics34.7%Endocrinology28.8%Intensive care medicine25.2%Anesthesia22.8%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank205/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank259/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.5
Articles / Year114
Total Citations17
2025
IF2.3
Articles / Year164
Total Citations201
2024
IF2.3
Articles / Year121
Total Citations485
2023
IF2.9
Articles / Year153
Total Citations1,081
2022
IF3.463
Articles / Year181
Total Citations1,630

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,718Scopus Q2SCImago Profile
Scopus Coverage:1981, 1983, 1985, 1987, 1990-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.815

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.52

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,199 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,213
3-Year Documents494
Citable Documents397

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate55.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
Pharmacology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Annals of Pharmacotherapy (abbr: ANN. PHARMACOTHER, ISSN: 1060-0280) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Inc. in United States since 1992. The periodical holds a Journal Impact Factor (JIF) of 2.50, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.815 (Q2), an H-index of 129.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 179 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,199 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
SAGE Publications Inc.
Publication Language
Multi-Language
Frequency
Monthly
Founding Year
1992
Indexing & Databases
SCIEScopusPubMed
Editorial Address
HARVEY WHITNEY BOOKS CO, PO BOX 42696, CINCINNATI, USA, OH, 45242

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: db650faa-a44c-402a-9952-0ed8a4093a67
Database Updated: 2026-10-01